
Which monoclonal antibody targets the interleukin‑6 (IL‑6) receptor and is approved for treatment of rheumatoid arthritis?
Medium
Create a free account to see more questions and build your own quiz.
Get StartedWhich monoclonal antibody targets the interleukin‑6 (IL‑6) receptor and is approved for treatment of rheumatoid arthritis?
Options:
- Tocilizumab
- Infliximab
- Rituximab
- Adalimumab
Correct answer: Tocilizumab
Explanation: Tocilizumab is an anti‑IL‑6 receptor monoclonal antibody that blocks IL‑6 signaling in inflammatory pathways. It was FDA‑approved for rheumatoid arthritis in 2010.
Created . Updated .